Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBT4CBT in Buprenorphine Maintenance
NCT03580902Phase 2Completed
- Sponsor
- CBT4CBT
- Start
- Jan 2019
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by CBT4CBT. Primary endpoint: Percent of urine toxicology screens that are negative for opioids at 12 weeks. Started Jan 2019; status: completed.
Beyond the preview
Go deeper on NCT03580902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03580902.